NASDAQ: OVID
Ovid Therapeutics Inc Stock Ownership - Who owns Ovid Therapeutics?

Insider buying vs selling

Have Ovid Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Margaret A. AlexanderPresident and COO2025-02-265,279$0.56
$2.96kSell
Jeffrey A. RonaCBFO2025-02-263,902$0.56
$2.19kSell
Margaret A. AlexanderPresident and COO2025-01-276,810$0.73
$4.97kBuy

1 of 1

OVID insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when OVID insiders and whales buy or sell their stock.

OVID Shareholders

What type of owners hold Ovid Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Takeda Pharmaceutical Co Ltd10.59%7,531,996$3.29MInsider
Takeda Pharmaceutical Co Ltd10.59%7,531,996$3.29MInstitution
Rubric Capital Management LP7.48%5,315,969$2.32MInstitution
Matthew During6.71%4,772,429$2.09MInsider
Blackrock Inc5.43%3,859,582$1.69MInstitution
Bvf Inc5.42%3,853,818$1.68MInstitution
Jeremy M. Levin5.14%3,652,176$1.60MInsider
Vanguard Group Inc4.37%3,108,781$1.36MInstitution
Madison Avenue Partners LP3.47%2,465,623$1.08MInstitution
Sio Capital Management LLC3.14%2,232,000$975.38kInstitution

1 of 3

OVID vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
OVID65.25%24.06%Net Selling
FGEN72.36%27.64%Net BuyingNet Buying
DYAI8.82%91.18%Net Buying
INKT0.26%99.74%Net BuyingNet Buying
CAMP42.49%57.51%Net Buying

Ovid Therapeutics Stock Ownership FAQ

Who owns Ovid Therapeutics?

Ovid Therapeutics (NASDAQ: OVID) is owned by 65.25% institutional shareholders, 24.06% Ovid Therapeutics insiders, and 10.69% retail investors. Takeda Pharmaceutical Co Ltd is the largest individual Ovid Therapeutics shareholder, owning 7.53M shares representing 10.59% of the company. Takeda Pharmaceutical Co Ltd's Ovid Therapeutics shares are currently valued at $3.16M.

If you're new to stock investing, here's how to buy Ovid Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.